These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15485399)

  • 1. The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes.
    Forbes JM; Thomas MC; Thorpe SR; Alderson NL; Cooper ME
    Kidney Int Suppl; 2004 Nov; (92):S105-7. PubMed ID: 15485399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of valsartan therapy on protein glycoxidation.
    Monacelli F; Poggi A; Storace D; Durante A; Traverso N; Viviani GL; Odetti P
    Metabolism; 2006 Dec; 55(12):1619-24. PubMed ID: 17142134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
    Motawi TK; El-Maraghy SA; Senousy MA
    J Biochem Mol Toxicol; 2013 Jul; 27(7):378-87. PubMed ID: 23733546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal hemodynamic effects of ACE inhibition in diabetic hyperfiltration: role of kinins.
    Komers R; Cooper ME
    Am J Physiol; 1995 Apr; 268(4 Pt 2):F588-94. PubMed ID: 7733315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.
    Kelly DJ; Cox AJ; Tolcos M; Cooper ME; Wilkinson-Berka JL; Gilbert RE
    Kidney Int; 2002 Jan; 61(1):31-9. PubMed ID: 11786082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal protective effect of valsartan in diabetic rats].
    Wen H; Lin S
    Zhonghua Nei Ke Za Zhi; 1999 Mar; 38(3):157-60. PubMed ID: 11798641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
    Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of renal tubular injury with a RAGE inhibitor FPS-ZM1, valsartan and their combination in streptozotocin-induced diabetes in the rat.
    Sanajou D; Ghorbani Haghjo A; Argani H; Roshangar L; Rashtchizadeh N; Ahmad SNS; Ashrafi-Jigheh Z; Bahrambeigi S; Asiaee F; Rashedi J; Aslani S
    Eur J Pharmacol; 2019 Jan; 842():40-48. PubMed ID: 30393200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
    Hegde LG; Yu C; Renner T; Thibodeaux H; Armstrong SR; Park T; Cheruvu M; Olsufka R; Sandvik ER; Lane CE; Budman J; Hill CM; Klein U; Hegde SS
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):495-504. PubMed ID: 21297495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
    Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
    Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and vasopeptidase inhibition.
    Wihler C; Schäfer S; Schmid K; Deemer EK; Münch G; Bleich M; Busch AE; Dingermann T; Somoza V; Baynes JW; Huber J
    Diabetologia; 2005 Aug; 48(8):1645-53. PubMed ID: 16010524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects.
    Morgan JM; Palmisano M; Piraino A; Hirschhorn W; Spencer S; Prasad PP; Ortiz M; Lloyd P
    Clin Pharmacol Ther; 1997 Jan; 61(1):35-44. PubMed ID: 9024172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of aliskiren and valsartan in mice with diabetic nephropathy.
    Wang W; Qiu L; Howard A; Solis N; Li C; Wang X; Kopp JB; Levi M
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):384-95. PubMed ID: 25031296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor.
    Xue C; Siragy HM
    Hypertension; 2005 Sep; 46(3):584-90. PubMed ID: 16043663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin II antagonism on the regression of kidney disease in the rat.
    Remuzzi A; Gagliardini E; Donadoni C; Fassi A; Sangalli F; Lepre MS; Remuzzi G; Benigni A
    Kidney Int; 2002 Sep; 62(3):885-94. PubMed ID: 12164870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension.
    Saiki A; Ohira M; Endo K; Koide N; Oyama T; Murano T; Miyashita Y; Shirai K
    Diabetes Res Clin Pract; 2006 Dec; 74(3):242-8. PubMed ID: 16713009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
    J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritubular capillary loss is ameliorated by ramipril or valsartan treatment.
    Zhang B; Chen N; Shi W; Wang W; Shi H; Yu H
    Microcirculation; 2008 May; 15(4):337-48. PubMed ID: 18464162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes.
    Qiang G; Zhang L; Yang X; Xuan Q; Shi L; Zhang H; Chen B; Li X; Zu M; Zhou D; Guo J; Yang H; Du G
    Eur J Pharmacol; 2012 Jun; 685(1-3):156-64. PubMed ID: 22546234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of valsartan on the expression of the receptor for advanced glycation end products in human glomerular mesangial cells].
    Zhong LN; Huang GL; Feng M; Zhang Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2011 Aug; 27(3):338-42. PubMed ID: 22097731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.